BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 32641726)

  • 21. Comparative preventive efficacy of ProHeart
    McTier TL; Holzmer S; Kryda K; Mahabir S; McCall JW; Trombley J; Maeder SJ
    Parasit Vectors; 2021 Apr; 14(1):226. PubMed ID: 33902689
    [TBL] [Abstract][Full Text] [Related]  

  • 22. First analysis of the secretome of the canine heartworm, Dirofilaria immitis.
    Geary J; Satti M; Moreno Y; Madrill N; Whitten D; Headley SA; Agnew D; Geary T; Mackenzie C
    Parasit Vectors; 2012 Jul; 5():140. PubMed ID: 22781075
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Establishment of macrocyclic lactone resistant Dirofilaria immitis isolates in experimentally infected laboratory dogs.
    Pulaski CN; Malone JB; Bourguinat C; Prichard R; Geary T; Ward D; Klei TR; Guidry T; Smith G'; Delcambre B; Bova J; Pepping J; Carmichael J; Schenker R; Pariaut R
    Parasit Vectors; 2014 Nov; 7():494. PubMed ID: 25376278
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Shifting the paradigm in Dirofilaria immitis prevention: blocking transmission from mosquitoes to dogs using repellents/insecticides and macrocyclic lactone prevention as part of a multimodal approach.
    McCall JW; Varloud M; Hodgkins E; Mansour A; DiCosty U; McCall S; Carmichael J; Carson B; Carter J
    Parasit Vectors; 2017 Nov; 10(Suppl 2):525. PubMed ID: 29143678
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of the efficacy of ProHeart
    Bowman DD; McTier TL; Adams EL; Mahabir SP; Login JA; Bidgood T; Woods DJ
    Parasit Vectors; 2017 Nov; 10(Suppl 2):502. PubMed ID: 29143654
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of oral moxidectin against susceptible and resistant isolates of Dirofilaria immitis in dogs.
    McTier TL; Six RH; Pullins A; Chapin S; McCall JW; Rugg D; Maeder SJ; Woods DJ
    Parasit Vectors; 2017 Nov; 10(Suppl 2):482. PubMed ID: 29143634
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preventive efficacy of oral moxidectin at various doses and dosage regimens against macrocyclic lactone-resistant heartworm (Dirofilaria immitis) strains in dogs.
    McTier TL; Six RH; Pullins A; Chapin S; Kryda K; Mahabir SP; Woods DJ; Maeder SJ
    Parasit Vectors; 2019 Sep; 12(1):444. PubMed ID: 31506088
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemoprophylactic effects of milbemycin oxime against larvae of Dirofilaria immitis during prepatent development.
    Grieve RB; Frank GR; Stewart VA; Parsons JC; Belasco DL; Hepler DI
    Am J Vet Res; 1991 Dec; 52(12):2040-2. PubMed ID: 1789519
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Macrocyclic lactone anthelmintic-induced leukocyte binding to Dirofilaria immitis microfilariae: Influence of the drug resistance status of the parasite.
    Berrafato T; Coates R; Reaves BJ; Kulke D; Wolstenholme AJ
    Int J Parasitol Drugs Drug Resist; 2019 Aug; 10():45-50. PubMed ID: 31054498
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The safety-net story about macrocyclic lactone heartworm preventives: a review, an update, and recommendations.
    McCall JW
    Vet Parasitol; 2005 Oct; 133(2-3):197-206. PubMed ID: 16198822
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is anthelmintic resistance a concern for heartworm control? What can we learn from the human filariasis control programs?
    Prichard RK
    Vet Parasitol; 2005 Oct; 133(2-3):243-53. PubMed ID: 16198824
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preventive efficacy of four or six monthly oral doses of 24 µg/kg moxidectin compared to six monthly doses of Heartgard® Plus or Interceptor® Plus against macrocyclic lactone-resistant heartworm (Dirofilaria immitis) strains in dogs.
    Kryda K; Holzmer S; Everett WR; McCall JW; Mahabir SP; McTier TL; Maeder SJ
    Parasit Vectors; 2020 Jul; 13(1):339. PubMed ID: 32660542
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 2005 Guidelines for the diagnosis, prevention and management of heartworm (Dirofilaria immitis) infection in dogs.
    Nelson CT; McCall JW; Rubin SB; Buzhardt LF; Dorion DW; Graham W; Longhofer SL; Guerrero J; Robertson-Plouch C; Paul A;
    Vet Parasitol; 2005 Oct; 133(2-3):255-66. PubMed ID: 16267884
    [No Abstract]   [Full Text] [Related]  

  • 34. Field study to investigate the effectiveness and safety of a novel orally administered combination drug product containing milbemycin oxime and lotilaner (Credelio
    Young LM; Wiseman S; Crawley E; Wallace K; Snyder DE
    Parasit Vectors; 2021 May; 14(1):284. PubMed ID: 34044864
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of a covered-rod silicone implant containing ivermectin for long-term prevention of heartworm infection in dogs.
    Cunningham CP; Brown JM; Jacobson GA; Brandon MR; Martinod SR
    Am J Vet Res; 2006 Sep; 67(9):1564-9. PubMed ID: 16948602
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Attributes, knowledge, beliefs, and behaviors relating to prevention of heartworm in dogs among members of a national hunting dog club.
    Rohrbach BW; Lutzy A; Patton S
    Vet Parasitol; 2011 Mar; 176(4):324-32. PubMed ID: 21310533
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Moxidectin: heartworm disease prevention in dogs in the face of emerging macrocyclic lactone resistance.
    Savadelis MD; McTier TL; Kryda K; Maeder SJ; Woods DJ
    Parasit Vectors; 2022 Mar; 15(1):82. PubMed ID: 35277180
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of four commercially available heartworm preventive products against the JYD-34 laboratory strain of Dirofilaria immitis.
    Blagburn BL; Arther RG; Dillon AR; Butler JM; Bowles JV; von Simson C; Zolynas R
    Parasit Vectors; 2016 Apr; 9():191. PubMed ID: 27044379
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of an injectable, sustained-release formulation of moxidectin in preventing experimental heartworm infection in mongrel dogs challenged 12 months after administration.
    Lok JB; Knight DH; Nolan TJ; Grubbs ST; Cleale RM; Heaney K
    Vet Parasitol; 2005 Mar; 128(1-2):129-35. PubMed ID: 15725542
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of 10% imidacloprid + 2.5% moxidectin topical solution (Advantage Multi
    Bowman DD; Ohmes CM; Hostetler JA; Keil DJ; Settje TL; Charles SD
    Parasit Vectors; 2017 Nov; 10(Suppl 2):478. PubMed ID: 29143660
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.